Skip to main content
logo
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
32.81
+0.03 (0.09%)
At close: Apr 28, 2026, 4:00 PM EDT
32.81
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Collegium Pharmaceutical Revenue

In the year 2025, Collegium Pharmaceutical had annual revenue of $780.57M with 23.62% growth. Collegium Pharmaceutical had revenue of $205.45M in the quarter ending December 31, 2025, with 12.92% growth.

Revenue (ttm)
$780.57M
Revenue Growth
+23.62%
P/S Ratio
1.36
Revenue / Employee
$1,845,312
Employees
423
Market Cap
1.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025780.57M149.12M23.62%
Dec 31, 2024631.45M64.68M11.41%
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018280.41M251.94M884.73%
Dec 31, 201728.48M26.77M1,564.29%
Dec 31, 20161.71M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Perrigo Company4.25B
Evotec SE925.65M
Tilray Brands858.28M
Pacira BioSciences726.41M
Amphastar Pharmaceuticals719.89M
Alvotech588.90M
Ironwood Pharmaceuticals296.15M
Harrow272.30M
Revenue Rankings

COLL News

More News